Cleveland Biolabs enters private placement agreement with strategic investor for $25M; Thermo Fisher opens manufacturing site in Scotland;

> Cleveland BioLabs ($CBLI) has entered into a private placement agreement with David Davidoich for $25 million in equity financing. Release

> Thermo Fisher ($TMO) opened a media manufacturing site in Scotland, which will manufacture products used for vaccines and biotherapeutics. Report

> Merck ($MRK) cut contractor jobs at its vaccine plant in Durham, NC. No full-time Merck employees were affected, the company said. More

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.